 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider |
|
| UNII |
|
| KEGG |
|
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H17NO3 |
| Molar mass | 235.283 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Eutylone (also known asβ-keto-1,3-benzodioxolyl-N-ethylbutanamine,bk-EBDB, andN-ethylbutylone) is astimulant andempathogenicdrug of thephenethylamine,amphetamine,phenylisobutylamine, andcathinone families which was developed in the 1960s,[3][4] which is classified as adesigner drug.[5] It was first reported to theEMCDDA in 2014 and became widespread internationally in 2019-2020 following bans on the related compoundephylone.[6][7][8][9] It is a synthetic cathinone.[9] In 2021, eutylone was the most common cathinone identified by the Drug Enforcement Administration in the United States.[10]
| DAT | NET | SERT |
|---|---|---|
| 120 ± 10 | 1280 ± 140 | 690 ± 50 |
Sweden's public health agency suggested classifying eutylone as a hazardous substance, on September 25, 2019.[11]
In the United States Eutylone is considered a schedule 1 controlled substance as apositional isomer ofPentylone.[12][13]
